Drug intelligence / Profile preview

Yunkang Oral Liquid

Development stage: Unknown
Lead developer: Anqing Echo Biopharmaceutical
Administration: Oral

Overview

Yunkang Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Anqing Echo Biopharmaceutical. It is specifically indicated for the treatment of threatened abortion and recurrent miscarriage (habitual abortion). The preparation is designed to nourish the kidneys, strengthen the spleen, and nourish the blood to stabilize pregnancy and prevent fetal loss. As a botanical combination product, it integrates multiple herbal ingredients that have been traditionally used in China to support maternal health and fetal development. It is currently approved and marketed in China for these obstetric indications.

Brand names: Yunkang Oral Liquid
Other names: 孕康口服液Yunkang Koufuye

Beyond the preview

Go deeper on Yunkang Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yunkang Oral Liquid.

Explore the full profile